Digraph

Extensively drug-resistant tuberculosis (XDR-TB)

Parent topics

This topic

Recent activity

You must be signed in to add and move topics and links.

2019-08 FDA approves Pretomanid Tablets in combination with bedaquiline and linezolid for treatment of XDR-TB
Linezolid Pretomanid United States Food and Drug Administration (FDA)Extensively drug-resistant tuberculosis (XDR-TB)
2020-03 Treatment of Highly Drug-Resistant Pulmonary Tuberculosis
Extensively drug-resistant tuberculosis (XDR-TB)
LAM4/KZN
Extensively drug-resistant tuberculosis (XDR-TB)
Clinical Use of the Meropenem-Clavulanate Combination for Extensively Drug-Resistant Tuberculosis - PubMed
https://pubmed.ncbi.nlm.nih.gov/22325421/
Extensively drug-resistant tuberculosis (XDR-TB)Meropenem-clavulanate
A bad patch
https://www.thehindu.com/opinion/open-page/a-bad-patch/article31069356.ece
Extensively drug-resistant tuberculosis (XDR-TB)
Stewardship / Resistance Scan for Dec 16, 2019 | CIDRAP
http://www.cidrap.umn.edu/news-perspective/2019/12/stewardship-resistance-scan-dec-16-2019
Extensively drug-resistant tuberculosis (XDR-TB)
Mumbai pharma company gets licence for breakthrough TB drug | India News - Times of India
https://timesofindia.indiatimes.com/india/mumbai-pharma-company-gets-licence-for-breakthrough-tb-drug/articleshow/71787870.cms
Pretomanid TB Alliance Extensively drug-resistant tuberculosis (XDR-TB)Bedaquiline-linezolid-pretomanid (BPaL)
The End Tuberculosis Now Act of 2019 - BORGEN
https://www.borgenmagazine.com/the-end-tuberculosis-now-act-of-2019/
Extensively drug-resistant tuberculosis (XDR-TB)